Case series of selective anti–tumor necrosis factor α therapy using infliximab in patients with nonresponsive chronic HLA–B27–associated anterior uveitis: Comment on the articles by Brandt et al
Open Access
- 16 October 2002
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (10) , 2821-2822
- https://doi.org/10.1002/art.10469
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Infliximab treatment of severe ankylosing spondylitis: One-year followupArthritis & Rheumatism, 2001
- Methotrexate therapy for chronic noninfectious uveitis: Analysis of a case series of 160 patientsOphthalmology, 2001
- Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic diseaseArthritis & Rheumatism, 2001
- Etanercept therapy in children with treatment-resistant uveitisArthritis & Rheumatism, 2001
- Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexateBritish Journal of Dermatology, 2001
- Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximabArthritis & Rheumatism, 2000
- Report on the 4thInternational Symposium of Ocular InflammationOcular Immunology and Inflammation, 1997